Esmya (ulipristal 5 mg) : retrait de l’autorisation de mise sur le marché (AMM) - Point d'information ANSM (08/09/2020)

Powered by eZ Publish™ CMS Open Source Web Content Management. Copyright © 1999-2014 eZ Systems AS (except where otherwise noted). All rights reserved.